On May 12, 2023 Panolos Bioscience reported that the company signed a consulting contract with MediRama (CEO Moon Hanlim) on May 3 (Presentation, Panolos Bioscience, MAY 12, 2023, View Source [SID1234633691]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Based on a high level of understanding of clinical development, MediRama provides a successful clinical performance strategy by acting as Biotech’s clinical development headquarters.

Through this contract, Panolos commenced MediRrama to consult on clinical development for the successful clinical performance of PB101/PB102, a key pipeline, and appointed CEO Moon Hanlim as a SAB (Scientific Advisory Board) to solidify a close partnership to devise Panolos’ pipeline portfolio operation strategy.